Emerging and Reemerging Infectious Diseases Journal Articles

• Consideration of Vector-Borne and Zoonotic Diseases This study suggests that while the prevalence of vector-borne and zoonotic diseases is on the rise in the U.S., they are often misdiagnosed and underreported by healthcare practitioners.
  Southern Medical Journal, June 03, 2021
• Tuberculosis -- United States, 2020 The annual decrease in tuberculosis reported in the U.S. during 2020 is far larger than any reported during the last decade. How might the COVID-19 pandemic have contributed to this steep decrease?
  Morbidity & Mortality Weekly Report, June 02, 2021
• COVID-19 Presenting With Bizarre Behavior and Encephalopathy This case of a patient who presented with bizarre behavior and found to have COVID-19 calls attention to encephalopathy and encephalitis as a potential presentation of COVID-19 disease.
  Journal of Medical Case Reports, May 27, 2021
• Laboratory-Associated Zika Virus Disease, U.S., 2016-2019 A new report highlights the potential risk for Zika infection among laboratory workers due to occupational exposure to the virus.
  Emerging Infectious Diseases, May 18, 2021
• Erythema Nodosum: A Practical Approach and Diagnostic Algorithm This review presents a diagnostic algorithm to optimize the initial work-up, differential diagnosis, and recommended therapies for erythema nodosum.
  American Journal of Clinical Dermatology, May 14, 2021
• Caspofungin With TMP/SMZ for Moderate-to-Severe PCP in HIV Is this combination treatment regimen an effective therapeutic option for pneumocystis pneumonia in HIV patients?
  HIV Medicine, May 05, 2021
• Radiological and Functional Lung Sequelae of COVID-19 A follow-up of COVID-19 patients provides insight into the radiological findings and lung function after recovery.
  BMC Pulmonary Medicine, April 28, 2021
• Quinacrine: Au Revoir or Adieu? Quinacrine is a safe and effective antimalarial agent. Does it have a place in the treatment of lupus?
  Current Opinion in Rheumatology, April 20, 2021
• COVID-19 and Emergencies in Patients With Diabetes Diabetic emergencies like diabetic ketoacidosis and hyperosmolar hyperglycemic state can be precipitated in patients with COVID-19, highlighting the need for close monitoring of these patients.
  Journal of Medical Case Reports, April 15, 2021
• Pulmonary Pathology of COVID-19 Following Severe Disease This retrospective case series details histologic lung pathology in the aftermath of severe COVID-19 managed with prolonged mechanical ventilation.
  American Journal of Clinical Pathology, April 12, 2021
• Severe Pulmonary Disease Caused by M kumamotonensis This report describes a case of severe pulmonary disease attributed to Mycolicibacter kumamotonensis. How was this patient diagnosed and treated?
  Emerging Infectious Diseases, April 08, 2021
• Bedaquiline for Disseminated NTM Infection in HIV Patients Could this novel antimycobacterial agent provide a safe and effective treatment option for NTM infections in HIV patients?
  Emerging Infectious Diseases, April 06, 2021
• Detection of MDR-TB Based on PCR-ELISA Hybridization Assay The authors developed a PCR-microplate hybridization assay for rapid and accurate detection of mutations responsible for resistance to TB therapeutics and prediction of drug susceptibility.
  Laboratory Medicine, March 31, 2021
• Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis Is myocarditis an important cause of myocardial injury in patients with COVID-19? This review suggests that COVID-19-induced myocarditis is an uncommon phenomenon.
  Journal of the American College of Cardiology, March 30, 2021
• Efficacy and Safety of Adalimumab Biosimilar CT-P17 for RA Is this adalimumab biosimilar for the treatment of rheumatoid arthritis as safe and effective as the reference product?
  Arthritis Research & Therapy, March 26, 2021
• E/C/F/TAF as Maintenance Treatment in HIV/HBV Patients Is this ART switch strategy a safe and effective means of maintaining viral suppression among HIV/HBV-coinfected individuals?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 18, 2021
• Asthma, SARS-CoV-2 and COVID-19 What have we learned about the interaction between asthma and COVID-19? Might asthma medications have an impact on outcomes?
  Current Opinion in Allergy and Clinical Immunology, March 18, 2021
• Risk of Adverse COVID-19 Outcomes for People Living With HIV Are people living with HIV at an increased risk for COVID-19-related adverse outcomes and mortality? Might certain ART regimens help mitigate the risk?
  AIDS, March 18, 2021
• Corticosteroids in COVID-19: Should It Be Standard-of-Care? Corticosteroids have provided a useful treatment option for COVID-19, but the benefits and drawbacks of this therapy should be considered.
  Journal of Clinical Rheumatology, March 17, 2021
• Brief Psychotic Disorder During COVID-19 Pandemic Might the intense psychosocial stress associated with a novel, potentially fatal disease along with lockdown restrictions be a trigger for first-episode psychosis?
  Schizophrenia Bulletin, March 16, 2021